Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An exploratory, randomized, double-blind, double-dummy, placebo- and active-controlled Phase II trial to evaluate the efficacy and safety of a topical application of GRT7019 in subjects with chronic pain due to knee osteoarthritis

Trial Profile

An exploratory, randomized, double-blind, double-dummy, placebo- and active-controlled Phase II trial to evaluate the efficacy and safety of a topical application of GRT7019 in subjects with chronic pain due to knee osteoarthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2018

At a glance

  • Drugs Diclofenac-hydroxyethylpyrrolidine/Lidocaine (Primary) ; Diclofenac; Lidocaine; Pantoprazole
  • Indications Pain
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Grunenthal
  • Most Recent Events

    • 20 Jan 2018 Status changed from recruiting to completed.
    • 11 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top